Alice P Taylor

Summary

Affiliation: Garden State Cancer Center
Country: USA

Publications

  1. ncbi Evaluation of a non-viral vaccine in smallpox-vaccinated individuals and immunized HLA-transgenic mice
    Alice P Taylor
    Center for Molecular Medicine and Immunology Garden State Cancer Center CMMI GSCC, 300 The American Road, Morris Plains, NJ 07950, USA
    Hum Immunol 73:612-9. 2012
  2. ncbi Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence
    Alice P Taylor
    Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, NJ, USA
    Int J Cancer 105:158-64. 2003
  3. ncbi Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts
    Alice P Taylor
    Garden State Cancer Center, Center for Molecular Medicine and Immunology, 520 Belleville Avenue, Belleville, NJ 07109, USA
    Mol Cancer Ther 6:524-31. 2007
  4. ncbi Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement
    A P Taylor
    Garden State Cancer Center, Center for Molecular Medicine and Immunology, 520 Belleville Avenue, Belleville, NJ 07109, USA
    Br J Cancer 103:82-9. 2010
  5. ncbi Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy
    Alice P Taylor
    Tumor Biology, Garden State Cancer Center, Belleville, New Jersey 07109, USA
    Clin Cancer Res 8:1213-22. 2002
  6. ncbi Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium
    Rosalyn D Blumenthal
    Garden State Cancer Center, Belleville, New Jersey 07109, USA
    Fertil Steril 78:1294-300. 2002
  7. ncbi Advantage of combining NLCQ-1 (NSC 709257) with radiation in treatment of human head and neck xenografts
    Maria V Papadopoulou
    Department of Radiation Medicine, Evanston Northwestern Healthcare, Evanston, Illinois 60201, USA
    Radiat Res 168:65-71. 2007

Detail Information

Publications7

  1. ncbi Evaluation of a non-viral vaccine in smallpox-vaccinated individuals and immunized HLA-transgenic mice
    Alice P Taylor
    Center for Molecular Medicine and Immunology Garden State Cancer Center CMMI GSCC, 300 The American Road, Morris Plains, NJ 07950, USA
    Hum Immunol 73:612-9. 2012
    ..vIL18BP, by eliciting human memory responses, is a viable antigen for inclusion in a virus-free vaccine. The immunogenicity of peptides was boosted by conjugation to L243, whether administered alone or combined...
  2. ncbi Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence
    Alice P Taylor
    Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, NJ, USA
    Int J Cancer 105:158-64. 2003
    ..Prevention of this angiogenic response to treatment may require administration of anti-angiogenic therapy during, rather than after, treatment...
  3. ncbi Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts
    Alice P Taylor
    Garden State Cancer Center, Center for Molecular Medicine and Immunology, 520 Belleville Avenue, Belleville, NJ 07109, USA
    Mol Cancer Ther 6:524-31. 2007
    ....
  4. ncbi Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement
    A P Taylor
    Garden State Cancer Center, Center for Molecular Medicine and Immunology, 520 Belleville Avenue, Belleville, NJ 07109, USA
    Br J Cancer 103:82-9. 2010
    ..The PlGF-mediated motility is prevented by an Flt-1-antagonising peptide, BP-1, and anti-PlGF antibody. The purpose of this study was to determine the intracellular effects of PlGF and the inhibiting peptide, BP-1...
  5. ncbi Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy
    Alice P Taylor
    Tumor Biology, Garden State Cancer Center, Belleville, New Jersey 07109, USA
    Clin Cancer Res 8:1213-22. 2002
    ..Antiangiogenic therapy may require a tumor-specific combination of inhibitors for PlGF, the angiopoietins, or their receptors, in addition to VEGF/flk-1...
  6. ncbi Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium
    Rosalyn D Blumenthal
    Garden State Cancer Center, Belleville, New Jersey 07109, USA
    Fertil Steril 78:1294-300. 2002
    ..To identify changes in expression of stimulatory and inhibitory factors when normal endometrium becomes menorrhagic...
  7. ncbi Advantage of combining NLCQ-1 (NSC 709257) with radiation in treatment of human head and neck xenografts
    Maria V Papadopoulou
    Department of Radiation Medicine, Evanston Northwestern Healthcare, Evanston, Illinois 60201, USA
    Radiat Res 168:65-71. 2007
    ..These results suggest a significant advantage in combining radiation with NLCQ-1 in treatment of human head and neck tumors, which are known to have hypoxic areas...